Recent News

• 09.17.2025 - S-3 - Registration statement under Securities Act of 1933
• 09.15.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 09.05.2025 - 8-K - Current report
• 09.04.2025 - D - Notice of Exempt Offering of Securities
• 09.02.2025 - PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
• 08.20.2025 - PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
• 08.18.2025 - 8-K - Current report
• 08.18.2025 - PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
• 08.11.2025 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 07.29.2025 - NT 10-K - Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT

Recent Filings

• 09.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 09.05.2025 - 8-K Current report
• 09.05.2025 - EX-99.1 EX-99.1
• 09.04.2025 - D Notice of Exempt Offering of Securities
• 08.18.2025 - 8-K Current report
• 08.18.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 07.29.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 04.24.2025 - 8-K Current report